India's Jagsonpal Pharma drops on sales hit after compliance issues at plant

Jagsonpal Pharmaceuticals

24/02/2025 05:01

** Shares of Jagsonpal Pharmaceuticals  JGSN.NS  slide as
much 4.4% to 210.03 rupees, last down 1.1% 
    ** Drugmaker gets U.S. FDA warning letter related to drug
listing, establishment registration after plant inspection
    ** Co estimates sales hit worth 35 mln rupees ($403,960) so
far in current fiscal year
    ** Stock down 10% YTD, it logged five straight years of
gains till 2024
 
 ($1 = 86.6420 Indian rupees)

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))